Division of Cardiovascular Diseases

clinical trials

Clinical Trials

Trial Title Condition Location
Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function Cardiorenal Syndrome Minnesota
Congestive heart failure (CHF)
Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction Myocardial Infarction Minnesota
Effects of Cranberry Juice on Risk Factors for Cardiovascular Disease Cardiovascular Diseases Minnesota
Heart Disease
Heart Disease Risk
Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function Atherosclerosis Minnesota
Heart Disease
Heart Disease Risk
Cardiovascular Diseases
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis Amyloid Minnesota
Establishment of Normal Ranges for Newly Developed Cardiovascular Assays Healthy Volunteers Minnesota
Healthy Volunteer
Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation Atrial Fibrillation Minnesota
Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial Coronary Artery Disease Minnesota
Exercise Stress Testing on Peripheral Gene Expression Using CORUS™ CAD Diagnostic Test Coronary Artery Disease Florida
Fat Gain and Cardiovascular Disease Mechanisms Hypertension Minnesota
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD) Coronary artery dissection Minnesota
Handheld Echocardiography in Clinical Practice Cardiovascular Diseases Minnesota
High Resolution Phenotyping in Healthy Humans Hypertension Minnesota
Human BNP (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function Cardiorenal Syndrome Minnesota
INcrease Of VAgal TonE in CHF Congestive heart failure (CHF) Florida
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III Atherosclerosis Minnesota
Mechanisms in Heart Failure With Normal EF Heart Failure Minnesota
Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson Stress Chronic Obstructive Pulmonary Disease Minnesota
Asthma
<<Previous 1  2  3  4  Next >>
Display All Pages


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.